Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation

Annals of Hepatology

Volumn 11, Issue 4, 2012, Pages 471-477

  Li, Chuan ^a   Wen, Tian Fu ^a   Yan, Lu Nan ^a   Li, Bo ^a   Yang, Jia Ying ^a   Xu, Ming Qing ^a   Wang, Wen Tao ^a   Wei, Yong Gang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Living donor liver transplantation; Model for end stage liver disease; Risk factor

Indexed keywords

ALBUMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ARTICLE; DIALYSIS; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ERYTHROCYTE TRANSFUSION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPONATREMIA; INTRAOPERATIVE PERIOD; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; CHI SQUARE DISTRIBUTION; CHINA; END STAGE LIVER DISEASE; HOSPITALIZATION; KAPLAN MEIER METHOD; KIDNEY DISEASE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

ADULT; CHI-SQUARE DISTRIBUTION; CHINA; END STAGE LIVER DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPONATREMIA; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862020925     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31460-7     Document Type: Article

References (29)

1. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses, J Hepatol 2010; 54: 1297-306.
2. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 2004; 291: 1871-4.
3. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805.
4. Nadalin S, Schaffer R, Fruehauf N. Split-liver transplanta tion in the high-MELD adult patient: are we being too cautious? Transpl Int 2009; 22: 702-6.
5. Selzner M, Kashfi A, Cattral MS, et al. Live donor liver transplantation in high MELD score recipients. Ann Surg 2010: 251: 153-7.
6. Alessandria C, Ozdogan O, Guevara M, et al, MELD score and clinical type predict prognosis in hepatorenal syndro me: relevance to liver transplantation. Hepatology 2005; 41: 1282-9.
7. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96.
8. Clavien PA, Sanabria J R, Strasberg SM. Proposed classifi cation of complications of surgery with examples of utility in cholecystectomy. Surgery 1992; 111: 518-26.
9. Dindo D, Demartines N, Clavien PA. Classification of surgi cal complications: a new proposal with evaluation in a co hort of 6336 patients and results of a survey. Ann Surg 2004: 240: 205-13.
10. Li C, Wen TF, Yan LN, et al. Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2011; 10: 248-53.
11. Hackworth WA, Heuman DM, Sanyal AJ, et al. Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int 2009; 29: 1071-7.
12. Dawwas MF, Lewsey JD, Watson CJ, Gimson AE. The impact of serum potassium concentration on mortality after liver transplantation: a cohort multicenter study. Transplantation 2009; 88: 402-10.
13. Kaido T, Egawa H, Tsuji H, Ashihara E, Maekawa T, Uemoto S. In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive ca ses at a single center. Liver Transpl 2009; 15: 1420-5.
14. Li C, Mi K, Wen TF, et al. Outcomes of patients with be nign liver diseases undergoing living donor versus decea sed donor liver transplantation. PLoS One 2011; 6: e27366.
15. Earl TM, Chari RS, Which types of graft to use in patients with acute liver failure? (A) Auxiliary liver transplant (B) Living donor liver transplantation (C) The whole liver. (C) I take the whole liver only.J Hepatol 2007; 46: 578-82.
16. Benson AB, Burton JR, Austin GL, et al. Differential effects of plasma and red blood cell transfusions on acute lung in jury and infection risk following liver transplantation. Liver Transpl 2011; 17: 149-58.
17. Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: Influen ce on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320-7.
18. Hendriks HG, van der Meer J, de Wolf JT, et al. Intraope rative blood transfusion requirement is the main determi nant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 2005; 17: 673-9.
19. Kim J, Yi NJ, Shin WY, Kim T, Lee KU, Suh KS. Platelet transfusion can be related to liver regeneration after li ving donor liver transplantation. World J Surg 2010; 34: 1052-8.
20. Tomimaru Y, Wada H, Marubashi S, et al. Fresh frozen plasma transfusion does not affect outcomes following he patic resection for hepatocellular carcinoma. World J Gastroenterol 2010; 16: 5603-10.
21. Park I, Moon E, Hwang JA, et al. Does hepatorenal syndro me affect the result of liver transplantation? Clinical ob servations. Transplant Proc 2010; 42: 2563-6.
22. Wyatt CM, Arons RR. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 2004; 78: 1351-5.
23. Nair S, Verma S, Thuluvath PJ. Pretransplant renal func tion predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179-85.
24. Dellon ES, Galanko JA, Medapalli RK, Russo MW. Impact of dialysis and older age on survival after liver transplanta tion. Am J Transplant 2006; 6: 2183-90.
25. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.
26. Carey RG, Bucuvalas JC, Balistreri WF, Nick TG, Ryckman FR, Yazigi N. Hyponatremia increases mortality in pedia tric patients listed for liver transplantation. Pediatr Transplant 2010; 14: 115-20.
27. Balderramo D, Prieto J, Cardenas A, Navasa M. Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxi city after liver transplantation. Transpl Int 2011; 24: 812-9.
28. Emiroglu R, Yilmaz U, Coskun M, Karakayali H, Haberal M. Higher graft-to-host ratio may decrease posttransplant mortality in patients with a high MELD score. Transplant Proc 2007; 39: 1164-5.
29. Yi NJ, Suh KS, Lee HW, et al. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small for size graft. Liver Transpl 2009; 15: 496-503.